XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

John Camm, A.; Amarenco, Pierre; Haas, Sylvia; Hess, Susanne; Kirchhof, Paulus; Kuhls, Silvia; van Eickels, Martin; G.G. Turpie, Alexander

doi:10.1093/eurheartj/ehv466

Public

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

Published in European Heart Journal • Sep 1, 2015

Authors:

A. John Camm

Pierre Amarenco

Sylvia Haas

Abstract

AIMS: Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, there is a need for safety and efficacy data from unselected patients in everyday clinical practice. XANTUS inve...

Subject

Medicine

Atrial fibrillation

Rivaroxaban

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!